Aiden Flynn

Aiden is the founder of Exploristics and has more than 20 years’ experience in drug discovery and clinical development. After seven years as a lecturer at University College, London, he spent ten years at GlaxoSmithKline as a director of statistical support for biomarker studies across research and development. He was responsible for developing and implanting the pharmacogenetics strategy that enabled the use of genetics data in clinical studies. This involved the integration of a wide range of capabilities across R&D such as new analysis tools and methods, bioinformatics, data standards, processing and training. In recent years, Aiden has worked closely with regulatory authorities, such as the FDA and EMEA, to develop tools and guidelines that support the use of biomarkers in clinical studies. Since founding Exploristics in 2009, Aiden has proven to be an innovative CEO, attracting over 50% of the world’s top pharmaceutical companies as clients as well as many biotechnology, device and dia